BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26360410)

  • 1. The Protein Tyrosine Phosphatase Rptpζ Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice.
    Baldauf C; Jeschke A; Kanbach V; Catala-Lehnen P; Baumhoer D; Gerull H; Buhs S; Amling M; Nollau P; Harroch S; Schinke T
    PLoS One; 2015; 10(9):e0137745. PubMed ID: 26360410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protein tyrosine phosphatase Rptpzeta is expressed in differentiated osteoblasts and affects bone formation in mice.
    Schinke T; Gebauer M; Schilling AF; Lamprianou S; Priemel M; Mueldner C; Neunaber C; Streichert T; Ignatius A; Harroch S; Amling M
    Bone; 2008 Mar; 42(3):524-34. PubMed ID: 18178537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoblast-specific inactivation of p53 results in locally increased bone formation.
    Liao N; Koehne T; Tuckermann J; Triviai I; Amling M; David JP; Schinke T; Luther J
    PLoS One; 2021; 16(11):e0249894. PubMed ID: 34793446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.
    Walia MK; Ho PM; Taylor S; Ng AJ; Gupte A; Chalk AM; Zannettino AC; Martin TJ; Walkley CR
    Elife; 2016 Apr; 5():. PubMed ID: 27070462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis.
    Haydon RC; Luu HH; He TC
    Clin Orthop Relat Res; 2007 Jan; 454():237-46. PubMed ID: 17075380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
    Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
    Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
    Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
    Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?
    Kendal JK; Singla A; Affan A; Hildebrand K; Al-Ani A; Ungrin M; Mahoney DJ; Itani D; Jirik FR; Monument MJ
    Clin Orthop Relat Res; 2020 Dec; 478(12):2921-2933. PubMed ID: 33275394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a temporal gene expression study.
    Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
    Exp Cell Res; 2020 Nov; 396(1):112263. PubMed ID: 32890459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formation.
    Ng AJ; Walia MK; Smeets MF; Mutsaers AJ; Sims NA; Purton LE; Walsh NC; Martin TJ; Walkley CR
    PLoS Genet; 2015 Apr; 11(4):e1005160. PubMed ID: 25859855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma.
    Thomas DM; Johnson SA; Sims NA; Trivett MK; Slavin JL; Rubin BP; Waring P; McArthur GA; Walkley CR; Holloway AJ; Diyagama D; Grim JE; Clurman BE; Bowtell DD; Lee JS; Gutierrez GM; Piscopo DM; Carty SA; Hinds PW
    J Cell Biol; 2004 Dec; 167(5):925-34. PubMed ID: 15583032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An EWS-FLI1-Induced Osteosarcoma Model Unveiled a Crucial Role of Impaired Osteogenic Differentiation on Osteosarcoma Development.
    Komura S; Semi K; Itakura F; Shibata H; Ohno T; Hotta A; Woltjen K; Yamamoto T; Akiyama H; Yamada Y
    Stem Cell Reports; 2016 Apr; 6(4):592-606. PubMed ID: 26997645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells.
    Wang JY; Wu PK; Chen PC; Lee CW; Chen WM; Hung SC
    Stem Cells Transl Med; 2017 Feb; 6(2):512-526. PubMed ID: 28191765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of osteoblastic differentiation on osteosarcomagenesis in the mouse.
    Quist T; Jin H; Zhu JF; Smith-Fry K; Capecchi MR; Jones KB
    Oncogene; 2015 Aug; 34(32):4278-84. PubMed ID: 25347737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt inhibitory factor 1 (WIF1) is a marker of osteoblastic differentiation stage and is not silenced by DNA methylation in osteosarcoma.
    Baker EK; Taylor S; Gupte A; Chalk AM; Bhattacharya S; Green AC; Martin TJ; Strbenac D; Robinson MD; Purton LE; Walkley CR
    Bone; 2015 Apr; 73():223-32. PubMed ID: 25571841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.
    Lengner CJ; Steinman HA; Gagnon J; Smith TW; Henderson JE; Kream BE; Stein GS; Lian JB; Jones SN
    J Cell Biol; 2006 Mar; 172(6):909-21. PubMed ID: 16533949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MET overexpression turns human primary osteoblasts into osteosarcomas.
    Patanè S; Avnet S; Coltella N; Costa B; Sponza S; Olivero M; Vigna E; Naldini L; Baldini N; Ferracini R; Corso S; Giordano S; Comoglio PM; Di Renzo MF
    Cancer Res; 2006 May; 66(9):4750-7. PubMed ID: 16651428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteogenic potential of murine osteosarcoma cells: comparison of bone-specific gene expression in in vitro and in vivo conditions.
    Gerstenfeld LC; Uporova T; Schmidt J; Strauss PG; Shih SD; Huang LF; Gundberg C; Mizuno S; Glowacki J
    Lab Invest; 1996 May; 74(5):895-906. PubMed ID: 8642785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential.
    Techavichit P; Gao Y; Kurenbekova L; Shuck R; Donehower LA; Yustein JT
    BMC Cancer; 2016 Nov; 16(1):869. PubMed ID: 27821163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone regeneration is regulated by wnt signaling.
    Kim JB; Leucht P; Lam K; Luppen C; Ten Berge D; Nusse R; Helms JA
    J Bone Miner Res; 2007 Dec; 22(12):1913-23. PubMed ID: 17696762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.